Petr Popov photo

Prof. Dr. Petr Popov

Associate Professor of Applied Mathematics and Computational Biology School of Science

Prof. Dr. Petr Popov is an Associate Professor of Applied Mathematics and Computational Biology at Constructor University Bremen, where he applies machine learning and computational methods to fundamental challenges in structural biology and pharmaceutical science. His research bridges the gap between data-driven modelling and molecular-level understanding of biological systems.

Key achievements: 40+ high-impact publications, h-index 25. One of the leading young researchers in computational drug discovery and machine learning for molecular design.

Research focus: Develops generative and predictive ML models for molecular structure analysis, with a focus on protein–ligand interactions and GPCR-targeted drug discovery. Combines computational biomolecular modelling, virtual screening, and deep learning to accelerate the early stages of drug design.

Machine learning for molecules: Designs neural architectures for molecular representation learning, docking score prediction, and de novo ligand generation. Work spans graph neural networks, transformer-based models, and multi-scale simulation approaches applied to drug targets.

Computer-aided drug discovery: Integrates structure-based and ligand-based methods with ML pipelines for target identification, hit discovery, and lead optimisation. Has contributed to studies on G protein-coupled receptors (GPCRs), a major class of therapeutic targets.

Research Portfolio

Prof. Dr. Petr Popov’s core expertise lies in developing physics-based machine-learning methods for molecular science and computational biology. Over the past fifteen years, he has built numerical approaches that accelerate scientific discovery across structural biology, drug discovery, protein engineering, and computational chemistry. His work spans the complete computational discovery pipeline: geometric and graph neural networks for molecular representation learning, deep learning for protein structure and binding-site prediction, AI-driven virtual screening, large language models for biological sequence analysis, and optimization methods for molecular design. Alongside methodological advances, he has translated these approaches into practical scientific software and patented technologies that are used to identify druggable targets, predict protein stability, design receptor mutations, and support structure-based drug discovery. Petr leads interdisciplinary collaborations spanning machine learning, structural biology, chemistry, and medicine while producing influential publications in leading journals.

What connects these activities – and what Petr brings to Constructor Labs – is the view that future breakthroughs in biology will depend on AI systems capable of both generating new scientific knowledge and communicating that knowledge effectively to human researchers. His work focuses on building AI that reasons across molecular structures, biological mechanisms, and experimental evidence, while producing tools that remain interpretable, reproducible, and directly useful to scientists. This combination of autonomous scientific reasoning, deployable software systems, and educational impact positions him to contribute across Constructor Labs’ research agenda, from AI-driven discovery in life sciences to the development of next-generation AI systems that augment both scientific research and human learning.

AI Agents for Life Science Research

Develops autonomous AI-assisted frameworks that combine LLM-based agents, modular MCP-enabled tools, and virtual experiment engines to streamline wet-lab protein engineering and bioinformatics workflows. The goal is to reduce repetitive manual analysis, enable continuous human–AI collaboration, and accelerate research cycles in areas such as protein thermostabilization, enzyme engineering, and antibody design.


Publications on Scopus

AI-agents for Life Science Industry